ClinicalTrials.gg
Enrolling by invitationNCT07783633CAN-BIND-iCBTUpdated Aug 27, 2026

Identifying Biomarkers of Response to Digital Interventions for Mood Disorders

An interventional study of Online Cognitive Behavioural Therapy in Depression / Major Depressive Disorder and Bipolar Disorder (BD), sponsored by Centre for Addiction and Mental Health. Enrolling by invitation at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Depression by Centre for Addiction and Mental Health — 6 open to participants now, 8 under way, none of them phase 3. Depression · Centre for Addiction and Mental Health.

Planned enrollment
10th of 46
200 · median 74
Started
2026
with 1 other
No phase
39 of 48
4 open now
Registered
48th of 48
by date

Among the 48 studies in Depression by Centre for Addiction and Mental Health, this one is the 10th largest by planned enrollment of the 46 interventional ones that give a count, is one of 2 that started in 2026, is one of 39 with no phase, and was the 48th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

6 of the 48 studies in Depression by Centre for Addiction and Mental Health are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 16 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Depression by Centre for Addiction and Mental Health, or all of them as a file.
02

Study summary

The proposed study will be a single-arm pragmatic clinical trial examining the feasibility of online CBT within the CAN-BIND sites and the biomarkers of treatment response to online CBT for mood disorders.

Read the detailed description

A total of 200 participants from the Canadian Biomarker Integration Network in Depression (CAN-BIND) network research sites will receive access to the Wellbeing Course for 8 Weeks with a 6-month follow-up period.

03

Conditions studied

  • Depression / Major Depressive Disorder
  • Bipolar Disorder (BD)

Keywords

  • Cognitive behavioral therapy
  • Online treatment
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Must be deemed to have capacity to provide ;
  2. Must sign and date the informed consent form;
  3. Stated willingness to comply with all study procedures;
  4. 16 years of age or older;
  5. Fluency in English;
  6. Meet lifetime criteria for a bipolar or depressive disorder as defined by the and assessed in a previous CAN-BIND study;
  7. Consent to the linkage of data to the previous CAN-BIND study

Exclusion criteria

Exclusion Criteria:

1. Exclusion criteria for the current study include not meeting inclusion criteria only

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Online Cognitive Behavioral Therapy

    The Wellbeing Course is an online intervention offered through the Online Therapy Unit to support people dealing with mood disorders. The course consists of 5 core lessons that provides psychoeducation on effective cognitive behavioural techniques for managing symptoms of depression and/or anxiety with short video overviews, client stories and interactive exercises. Participants will engage with the course for 8-weeks during the intervention period but will receive access for 1-year. Participants will also complete study assessments after the intervention period and then bimonthly assessments during the follow-up phase.

    Behavioral: Online Cognitive Behavioural Therapy

Interventions

  • BehavioralOnline Cognitive Behavioural Therapy

    The Wellbeing course is an online program that educates and guides users in cognitive behavioural therapy techniques with downloadable guides, client stories and interactive exercises to help manage symptoms of mood concerns.

    Also known as: Wellbeing Course

06

What researchers measure

Primary outcomes

  1. Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)

    A widely used and well-validated, 16-item measure of depression symptoms. Minimum score is 0 and Maximum score is 27, with higher scores indicating severe depression.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

Secondary outcomes

  1. Patient Health Questionnaire - 9 (PHQ-9)

    A widely used and well-validated, 9-item measure of depression symptoms. Minimum score is 0 and Maximum score is 27, with higher scores indicating severe depression.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  2. Generalized Anxiety Disorder - 7 (GAD-7)

    A widely used and well-validated, 7-item measure of symptoms of anxiety. Minimum score is 0 and Maximum score is 21, with higher scores indicating severe anxiety.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  3. Snaith-Hamilton Pleasure Scale (SHAPS)

    A widely used and well-validated 14-item measure of the ability to experience pleasure. Minimum score is 0 and Maximum score is 14, with higher scores indicating greater pleasure.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  4. Work and Social Adjustment Scale (WSAS)

    A 5-item measure of the impact of mental health conditions on daily functioning. Minimum score is 0 and Maximum score is 40, with higher scores indicating greater impairment in overall functioning.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  5. The World Health Organization-Five Well-Being Index (WHO-5)

    A 5-item short form of quality of life across multiple domains. Raw scores range from 0 to 25 and can be converted to a percentage score ranging from 0 to 100, with higher scores indicating better mental well-being.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  6. Perseverative Thinking Questionnaire (PTQ)

    A 15-item measure that assesses the underlying process of repetitive negative thinking, independent of specific thought content or diagnostic category. Minimum score is 0 and Maximum score is 60, with higher score indicating more frequent and intrusive negative thought patterns.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  7. Ruminative Response Scale (RRS) - Brooding Subscale

    A 5-item measure of maladaptive rumination. Minimum score is 5 and Maximum score is 20, with higher scores indicating greater brooding.

    Time frame: Baseline, Week 8, Week 16, Week 24, Week 32

  8. Childhood Experience of Care and Abuse Questionnaire (CECA.Q)

    A self-report measure assessing negative childhood experiences before age 17, including Neglect and Abuse. Sub-scale scores are derived by summing relevant items, with established cut-offs for severity of Neglect, Antipathy, Physical and Sexual abuse. Minimum score for Antipathy or Neglect is 8 and Maximum score is 40. A cutoff of \>=25 for severity of Antipathy mother/father while cutoff for severity of Neglect is \>=22 for mother and \>=24 for father. Minimum score for severity of Physical abuse is 0 and Maximum score is 4. Minimum score for severity of Sexual abuse is 0 and Maximum score is 7. The cutoff for severity of Physical and Sexual abuse is \>=1. Higher scores across all subscales (Antipathy, Neglect, Physical abuse, Sexual abuse) indicates greater severity. Loss and Support are also reported in this measure and scored as present or absent. Loss reflects parental death before age 17 or separation of 1+ year while Support reflects presence of at least one support figure.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — This study is funded by Ontario Brain Institue (OBI). Data collected during the duration of the study will be entered into a database known as "Brain-CODE", which is an open-access database with high level security protocols that allows for the sharing of coded data with other researchers in Canada or around the world.

Supporting information: Study protocol

Time frame: Within 12 months of study completion

Access criteria: Access to IPD and supporting information is through submission of a detailed research analysis proposal that will be reviewed by Ontario Brain Institute (OBI) and the executive committees of Canadian Biomarker Integration Network in Depression (CAN-BIND). For researchers outside Canada or not affiliated with CAN-BIND, they will need to establish a Data Use Agreement with OBI before they can access any data from CAN-BIND.

Data sharing details ↗ · braininstitute.ca

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2029, 36 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 36 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2026
First posted
Aug 25, 2026
StartActual
Jul 28, 2026
Primary completionEst.
Jul 28, 2029
CompletionEst.
Jul 28, 2029
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07783633
Collaborators
Ontario Brain Institute, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, Dalhousie University, University of Michigan, Simon Fraser University, Ontario Shores Centre for Mental Health Sciences, University of Regina, University of Texas Southwestern Medical Center, University Health Network, Toronto, St. Joseph's Healthcare Hamilton, Nova Scotia Health Authority, The Canadian Biomarker Integration Network in Depression
Responsible party
Lena Quilty (Associate Professor, Centre for Addiction and Mental Health) — Principal investigator
First posted
Aug 25, 2026
Start date
Jul 28, 2026
Primary completion
Jul 28, 2029 (estimated)
Completion
Jul 28, 2029 (estimated)
Last update
Aug 27, 2026

Study contacts

Lena C. Lena, PhD
principal investigator · Centre for Addiction and Mental Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion